P-selectin-deficient mice to study pathophysiology of sickle cell disease
- PMID: 31968076
- PMCID: PMC6988409
- DOI: 10.1182/bloodadvances.2019000603
P-selectin-deficient mice to study pathophysiology of sickle cell disease
Erratum in
-
Bennewitz MF, Tutuncuoglu E, Gudapati S, et al. P-selectin-deficient mice to study pathophysiology of sickle cell disease. Blood Adv. 2020;4(2):266-273.Blood Adv. 2020 Mar 10;4(5):803. doi: 10.1182/bloodadvances.2020001643. Blood Adv. 2020. PMID: 32109283 Free PMC article. No abstract available.
Abstract
P-selectin–deficient SCD mice are protected from lung vaso-occlusion.
P-selectin–deficient SCD mice will be useful in assessing the benefits of anti–P-selectin therapy in diverse complications of SCD.
Conflict of interest statement
Conflict-of-interest disclosure: The authors declare no competing financial interests.
Figures


References
-
- Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018-2031. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases